AVS Bio, a company backed by Arlington Capital Partners, has acquired Biorbyt. The financial terms of the acquisition were not disclosed.
AVS Bio Completes Acquisition of Biorbyt
AVS Bio Completes Acquisition of Biorbyt
AcquisitionManufacturingUS
Get the full Biorbyt company profile
Access contacts, investors, buying signals & more
Acquired
Biorbyt
United StatesManufacturing
Undisclosed amount
September 23, 2026
Acquirer
AVS Bio
Unlock GTM signals
Discover Biorbyt's tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at Biorbyt.